Certolizumab Pegol for the Treatment of Patients with Moderate-to-Severe Chronic Plaque Psoriasis: An Overview of 3 Randomized Controlled Trials. J of Skin [Internet]. 2018 Feb. 23 [cited 2025 May 18];2(S1):S3. Available from: https://skin.dermsquared.com/skin/article/view/306